Solventum Corporation announced the pricing of a secondary offering of 8,800,000 shares of its common stock.
The offering is expected to result in gross proceeds of approximately $648 million to 3M Company, the Selling Shareholder.
The Offering is set to close on or about Aug. 15, 2025, subject to customary closing conditions.
Secondary Offering Details
8,800,000 shares of common stock to be sold with gross proceeds of approximately $648 million.
Underwriters
Goldman Sachs & Co. LLC and BofA Securities are acting as the underwriters for the Offering.
Offering Procedure
The shares are offered through the Company's shelf registration statement and a preliminary prospectus supplement.
- The secondary offering will provide significant funds to the Selling Shareholder, 3M Company.
- The selection of reputable underwriters like Goldman Sachs & Co. LLC and BofA Securities enhances investor confidence in the Offering.
Solventum's successful pricing of the secondary Offering reflects positive market reception and investor interest in the company's common stock.